Prospective multicentre open-label randomised controlled trial of 3-month versus 12-month dual antiplatelet therapy after implantation of the new generation biodegradable polymer sirolimus TARGET-eluting coronary stent: protocol of the TARGET DAPT trial.
Hongbo YangFeng ZhangJi'e YangMing ZhengRuifen CaoYuxiang DaiChenguang LiKang YaoJuying QianJun-Bo Genull nullPublished in: BMJ open (2019)
NCT03008083.
Keyphrases
- antiplatelet therapy
- study protocol
- open label
- randomized controlled trial
- percutaneous coronary intervention
- acute coronary syndrome
- clinical trial
- phase iii
- phase ii
- coronary artery disease
- coronary artery
- drug delivery
- phase ii study
- double blind
- squamous cell carcinoma
- placebo controlled
- radiation therapy
- heart failure
- cross sectional
- left ventricular
- lactic acid